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Background:  Noroviruses  (NoV)  have  been  shown  to be an  important  cause  of  morbidity  and  mortality
in children  worldwide,  only  second  after  Group  A  rotaviruses  (RVA).  In  Paraguay,  acute  gastroenteritis
(AGE)  is the  third  cause  of  mortality  in  children  ≤5  years  old.
Objectives:  To  analyze  the  presence  and  diversity  of NoV  in Paraguayan  children  ≤5  years  old  presenting
AGE.
Study  design:  Three  hundred  seventy  eight  fecal  samples,  negative  for  pathogenic  bacteria  and  RVA,  were
collected  from  children  admitted  as ambulatory  and  hospitalized  patients  in  a  large  private  hospital
from  Asuncion,  Paraguay  from  2004  to  2005.  The  presence  and  diversity  of  NoV  was  determined  by two
different  RT-PCR  strategies  and  nucleotide  sequencing.
Results:  One  hundred  and  sixty  one  samples  were  positive  for NoV  by  partial ampliﬁcation  of  the  viral
polymerase  gene  (RdRp).  No  seasonality  or differences  in  the  viral  prevalence  for  the  different  age-groups
were detected.  GII  and  GI  NoVs  were  associated  to 58% and  42%  of  the  infections,  respectively.  The geno-
type  was  determined  in 18%  (29/161)  NoV-positive  samples.  The  genotypes  detected  were:  GII.4  (18%),
GII.17 (18%),  GII.6  (14%),  GII.7  (14%),  GII.3  (10%),  GII.5 (3%),  GII.8  (3%),  GII.16  (3%),  GI.3 (14%)  and  GI.8  (3%).
Ampliﬁcation  of  the  ORF2  from  the  GII.4  strains  showed  the  presence  of a new  GII.4  variant.
Conclusions:  The  results  showed  a continuous  circulation  of NoV  in  children  throughout  the  two  years  of
study  and  an  extensive  diversity  of  genotypes  co-circulating,  highlighting  the  need  for  better  surveillance
of NoV  in  Paraguayan  children.
© 2013 Elsevier B.V. All rights reserved.. Background
Acute gastroenteritis (AGE), both epidemic and sporadic, are
ommon causes of morbidity and mortality in people of all ages
1]. According to Black et al., 1.336 million of deaths occur annu-
lly in children ≤5 years old due to diarrheic infections worldwide
2]. Noroviruses (NoV) are considered the most common cause of
GE outbreaks in adults worldwide and the second most frequent
iral agent causing AGE in young children after group A rotavirus
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386-6532/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.jcv.2013.07.008(RVA) [3,4]. In developing countries, NoV have been estimated to
cause around 1.1 million hospitalizations and up to 200,000 chil-
dren deaths annually [5].
NoV are small (27–38 nm in diameter), non-enveloped viruses
that belong to the Caliciviridae family. The single-stranded,
positive-sense genome is organized in three open reading frames
(ORFs): ORF1 encodes for 6 nonstructural (NS) proteins, including
the RNA-dependent RNA polymerase (RdRp); ORF2 encodes the
major capsid protein (VP1); and ORF3 encodes the minor capsid
protein (VP2) [6]. The marked genetic diversity presented by NoV
prompted the development of multiple protocols for detection and
molecular characterization, which target different regions of the
ORF1 and ORF2 [7–11].
Based on sequence differences on the VP1, NoV have been classi-
ﬁed into six genogroups (GI–GVI), and multiple genotypes [11,12].
NoV from GI, GII, and GIV have been shown to infect humans, being
the GII.4 strains the most prevalent. Although GII.4 strains have
been shown to be the main cause of AGE outbreaks worldwide,
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ther NoV strains (e.g. GII.3) have been shown at high incidence in
poradic cases of diarrhea in children ≤5 years old [13].
In Paraguay, AGE is considered the third cause of mortality in
hildren ≤5 years old [14]. Since 1998, epidemiological studies
ave been carried out to determine the role of RVA in the etiology
f non-bacterial AGE infections in Paraguayan children, indicating
hat is responsible for approximately 25% of all AGE infections in
hat population [15,16].
. Objectives
To analyze the presence and diversity of NoV in children ≤5
ears old with AGE, previously determined negative for RVA and
nteric pathogenic bacteria.
. Study design
.1. Sample collection
A total of 927 fecal samples were collected from children ≤5
ears old with non-bacterial AGE who were admitted as ambu-
atory and hospitalized patients in a large private hospital from
suncion, Paraguay between January 2004 and December 2005.
ll samples were screened for RVA [17]. Approximately 50% of the
VA-negative samples from each month were randomly selected
or NoV screening (378 out of 701 RVA-negative samples; 161 col-
ected during 2004 and 217 during 2005). In months were a low
umber of samples was originally collected, at least 10 samples
ere selected if enough material was available. In only two months
March and May, 2004) less than 10 samples were selected (6 and
, respectively) for NoV screening. No data on whether the patients
ere linked to outbreaks or serious cases of gastroenteritis was
ollected.
.2. RNA extraction and PCR ampliﬁcation
Viral RNA was extracted from 10% fecal suspension in
ris–HCl–Ca++ [0.01 M]  (pH: 7.2) buffer using guanidine isoth-
ocyanate/silica method, as described by Boom et al. [18].
everse transcription was carried out using random primers
Invitrogen®, Carlsbad, CA, USA). For NoV detection, generic
rimers (Mon431/Mon432 and Mon433/Mon434) that target the
egion B of the ORF1 (RdRp gene) [7], were used according to
he conditions described by Beuret et al. [19]. The molecular
haracterization was performed by using degenerated primers
apA/CapB1/CapB2 and CapC/CapD1/CapD3 that target the VP1
ene (region D) as described by Vinjé et al. [9]; and the primers
V12Y, JV12i, Ni-R and G1 that target the RdRp gene as described
reviously by Boxman et al. [10]. PCR products were resolved on 2%
garose gel electrophoresis, followed by ethidium bromide stain-
ng, and the images were obtained using the Kodak Gel Logic 212
mage capture system (Carestream Health Inc., Upland, CA, USA).
.3. Nucleotide sequencing and bioinformatic analyzes
PCR products from the region D were puriﬁed directly from
he agarose gels using the QIAquick® Gel extraction kit (QIAGEN®,
alencia, CA, USA) in accordance with manufacturer’s instructions.
ucleotide sequencing was carried out using both primers and
ig Dye Terminators v3.0 and an automated sequencer ABI PRISM
730 Genetic Analyzer (Applied Biosystems®, Foster City, CA, USA).
he GII.4 strain characterization was performed by sequencing
he PCR product of the entire ORF2 with GII.4-speciﬁc primers
hat target the 5′ and 3′ end of the ORF2. Internal primers were
esign to cover nearly the full ORF2 (primers available uponFig. 1. Frequency of norovirus infections in children with acute gastroenteritis in
Asuncion, Paraguay by age-group.
request). All sequencing reactions were repeated at least twice
to verify the accuracy of the differences. The sequences obtained
were analyzed with BioEdit v.7.0.9.0 software, using Clustal W for
sequence alignment [20]. The phylogenetic trees were constructed
using the Neighbor-Joining method and Kimura 2-parameter as
a model of nucleotide substitution using the MEGA v4.0 software
package [21]. The statistical signiﬁcance was  estimated by boot-
strap method (1000 pseudo-replicates). The nucleotide sequences
(≥200 pb) reported in this study are available at GenBank database
under the accession numbers: KC736563–KC736586. The X-ray
solved structure of the VP1 from TCH0 5 (Protein Data Bank [PDB]
accession number: 3SKB) was  used to identify the antigenic sites
and differences among GII.4 strains. Figure was rendered using
MacPyMol (DeLano Scientiﬁc LLC).
4. Results
4.1. Viral detection
NoV genome was  detected in 161 (43%) of 378 analyzed sam-
ples. All age groups presented similar frequencies of NoV infection
(Fig. 1). NoV infection was  detected throughout the year, with
peaks distributed across different months (Fig. 2). Climatic data
like mean temperature, relative humidity and rainfall was obtained
from the Climate Department of the Meteorology and Hydrology
Service from the Ministry of Defense (Paraguay); and no relation-
ship between NoV infections and those factors was observed in this
study (data not shown).
4.2. Noroviruses characterization
NoV genogroup was  determined in 84 out of 161 positive sam-
ples using region B and/or region D ampliﬁcation. GII strains were
detected in 54.7% (46/84) of the samples, GI in 40.5% (34/84),
and GI/GII mixed infections were observed in 4 samples (4.7%).
Partial sequence of the ORF2 was obtained from 29 samples
(Table 1). Paraguayan GI strains were classiﬁed into two  geno-
types: GI.3 and GI.8 (Fig. 3). Norovirus GI.3 strains were grouped
in two phylogenetic clusters: GI.3a and GI.3b [22]. Three out of
the four GI.3 Paraguayan strains grouped with the prototype strain
Hu/Osaka/010314/2001/JP (EF547393) within the cluster GI.3b
[23]; while the strain Py830SR05 was  related to Brazilian GI.3a
samples detected during 2006 and 2007 [24,25] and the prototype
strain Hu/DesertShield395/1993/US (U04469), described in USA
soldiers in Saudi Arabia in the 1990s [26]. The strain Py698SR04,
was  related to the Boxer strain responsible for viral AGE outbreaks
on USA Navy Ships in 2001, and was, therefore, classiﬁed as geno-
type GI.8.
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Fig. 2. Monthly distribution of norovirus infections in children with acute gastroenteritis in Asuncion, Paraguay. The number of analyzed samples (gray bars), norovirus-
positive samples (black bars) and percentage of norovirus infections (line) are shown for each month.
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Fig. 3. Phylogenetic tree of the partial gene from major capsid protein of GI norovirus strains detected in Paraguayan children during 2004–2005. The tree was  constructed
using  Kimura 2-parameter as a nucleotide substitution model and Neighbor-Joining for tree reconstruction. The statistical signiﬁcance was estimated by bootstrap method
(1000 pseudo-replicates). Bootstrap values are shown at the branch nodes (values <70% not shown). The Paraguayan strains are marked with a ﬁlled circle. For each strain
(where  available), name, country of origin, year of isolation and GenBank accession numbers are shown.
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Table  1
Norovirus (NoV) genotypes circulating in Asuncion, Paraguay during 2004–2005.
NoV genotypes No. of samples
2004 2005 Total (%)
GI.3 1 3 4 (14)
GI.8 1 0 1 (3)
GII.3 3 0 3 (10)
GII.4 2 3 5 (18)
GII.5 0 1 1 (3)
GII.6 3 1 4 (14)
GII.7 0 4 4 (14)
GII.8 1 0 1 (3)
GII.16 0 1 1 (3)
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Fig. 4. Phylogenetic tree of the partial gene from major capsid protein of GII
norovirus strains detected in Paraguayan children during 2004–2005. Tree recon-GII.17 2 3 5 (18)
Total 13 16 29
Eight genotypes from GII were detected in 24 Paraguayan sam-
les: GII.3, GII.4, GII.5, GII.6, GII.7, GII.8, GII.16 and GII.17 (Table 1,
ig. 4). GII.4, GII.6, GII.8 and GII.17 were found in both years, while
II.3 strains were found in samples collected in 2004, and GII.5
nd GII.7 in samples collected in 2005 (Table 1). To further char-
cterize the Paraguayan GII.4 strains, the ORF2 (nt 5130–6688;
ased on Hunter504D [GB: DQ078814]) was sequenced and com-
ared with representative GII.4 strains from each of the described
lusters. The phylogenetic analysis grouped the GII.4 Paraguayan
trains between the Hunter and the Yerseke clusters (Fig. 5a).
mportantly, when the nucleotide sequence was submitted to the
orovirus Genotyping Tool v1.0 [27], the GII.4 cluster could not
e assigned. Thus, although nucleotide and amino acid differences
howed high similarity of the Paraguayan strains with Hunter-like
nd Yerseke strains (Fig. 5b); analyzes of the amino acids involved
n important antigenic sites [28–30], showed three differences in
ntigenic sites A and E (Fig. 5c) when compared with Hunter-like
nd Yerseke strains. Therefore, the phylogenetic clustering and the
mino acid analyzes suggest that these strains belong to a new
II.4 cluster. Because the phylogenetic analyzes of the region D
lustered together Paraguayan and Brazilian GII.4 strains (data not
hown) we tentatively named “South-American cluster” to this
ewly described GII.4 variant.
. Discussion
In this study, we sought to determine the presence and molecu-
ar diversity of NoV associated to AGE cases in Paraguayan children
5 years old. Forty three percent (161/378) of the analyzed sam-
les were positive for NoV. This incidence may  be higher than
reviously reported [31–33], due that only samples negative for
acteria and RVA were selected for this study; however, several
eports have shown similar incidences among RVA-negative sam-
les [13,34]. NoV are usually referred as “stomach ﬂu viruses”
ecause of their high incidence in outbreaks of AGE during the
inter season [31,33,35,36]; however, in Paraguay NoV-positive
amples were observed over the two years of study with no sea-
onal pattern. This lack of seasonality is consistent with previous
eports for this geographic region [24,37].
NoV genetic diversity has lead to the development of sev-
ral strategies for detection and molecular characterization, which
arget different regions for genome ampliﬁcation. Consequently,
ombined molecular methods were recommended for accurate
oV identiﬁcation and characterization [9,38,39]. Following this
pproach, two different ampliﬁcation protocols targeting RdRp
ene (region B) and the major capsid protein gene (region D) were
pplied in this study [9,10]. The identiﬁcation of the genogroup was
nly possible in approximately 50% of the NoV-positive samples.
ifferences in the primer-binding site of the Paraguayan strains
ould explain the low success of molecular characterization. GI and
struction methods as described in Fig. 3 and Study Design section. The Paraguayan
strains are marked with a ﬁlled circle. For each strain (where available), name,
country of origin, year of isolation and GenBank accession numbers are shown.
382 M.E. Galeano et al. / Journal of Clinical Virology 58 (2013) 378– 384
Fig. 5. Characterization of the GII.4 strains detected in Paraguay. (a) Phylogenetic tree of the VP1 region from GII.4 noroviruses. Representative strains from each GII.4 cluster
were  used to compare with the Paraguayan GII.4 strains (marked with a circle). For each strain the name/year of isolation/country/GenBank accession number was  provided.
(b)  Percentage of nucleotide (NT) and amino acid (AA) differences from the Paraguayan GII.4 strain (Py735SR04) and each of the strains described in the phylogenetic tree. (c)
Amino acid differences at the antigenic sites (A–E) from Paraguayan GII.4 strains and representative GII.4 strains. Differences between the Paraguayan strain (Py735SR04) and
the  Hunter284E and Yerseke38 strains are highlighted in blue. Same amino acid differences were detected with the Paraguayan strain Py794SR05. The antigenic sites (A–E)
are  indicated in light green in the dimeric structure from the TCHO5 strain (PDB: 3SKB). Top and side view of the dimer are shown as indicated. The dashed line indicates the
line  of symmetry between the two monomers. (For interpretation of the references to color in the text, the reader is referred to the web version of the article.)
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II strains were detected at similar frequencies, being 40.5% and
4.7%, respectively. The remaining samples (4.7%) showed GI/GII
ixed infections, which was not surprising considering the high
requencies of both GI and GII. Several reports have shown the
redominance of GII strains over GI, at rates of 90% and 10%, respec-
ively; in both outbreaks and sporadic AGE cases [5,25,40–43].
owever, Soares et al. have shown similar incidences of GI/GII
trains in children <10 years old from Rio de Janeiro, Brazil [24],
hich might reﬂect a particular pattern of circulation in South-
merican countries and non-epidemic settings. More accurate
haracterization of the samples is needed to conﬁrm these ﬁndings.
In this study, the NoV genotype was determined in 29 sam-
les. Ten different genotypes were identiﬁed, and all of them
resented similar frequencies (3–18%); suggesting that multiples
enotypes were circulating in Paraguayan children with AGE dur-
ng 2004–2005. This is in contrast with previous studies that have
hown the large predominance of one or two strains (in most
ases GII.4 and GII.3) in both outbreaks and sporadic cases of AGE
39,40,44,45]. Even though a small number of strains were char-
cterized, this study shows that multiple NoV genotypes, rather
han single strain, could be responsible for AGE in Paraguayan chil-
ren. Interestingly, GII.5 strains are being reported for the ﬁrst time
n South America, which expands the diversity of NoV reported for
his geographic area. GII.3 strains, the second most prevalent geno-
ype in the world, were described in the 1990s and early 2000s
n Argentina [46] and Brazil [25,47], respectively. In Paraguayan
hildren, GII.3 strains were observed in three samples collected in
eptember and October 2004, and were phylogenetically related to
he Brazilian strains that circulated in 2003. GII.17 strains were ini-
ially described in the USA [48], and later in Argentina [41], Brazil
49] and Nicaragua [33]. In Paraguay, GII.17 strains were found in
anuary 2004 and mid-2005, suggesting that this genotype have
een circulating in the Americas for over a decade.
GII.4 strains have been shown to be the predominant NoV strains
orldwide [4,6,30,42]. The chronological emergence of new phy-
ogenetic clusters and changes in one of the ﬁve antigenic sites
A–E) described in the VP1 from GII.4 strains has shown to corre-
ate with large local and global epidemics [28–30,50]. A new GII.4
ariant that has been circulating in South American children since
003 it is being described here. Strains from this cluster showed
igh similarity with prototype strains from two  GII.4 clusters, but
ifferences on the antigenic sites A and E as well as phylogenetic
nalyses conﬁrms the new variant. Interestingly, these GII.4 strains
rom the South-American cluster have been detected in children
ith sporadic cases of AGE, but not associated to outbreaks so far.
In conclusion, the ﬁndings reported in this study, i.e. the con-
inuous circulation of NoV throughout the year and the extensive
iversity of genotypes detected, highlight the need for better
urveillance of NoV in Paraguayan children population and other
atin American countries. This is particularly important because
he RVA vaccine was introduced in the National Immunization Pro-
ram from many countries in Latin America [51], and the NoV could
ecome the major viral pathogen of diarrhea in children under ≤5
ears old.
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